Efficacy and safety of sofosbuvir/velpatasvir in a real-world chronic hepatitis C genotype 3 cohort | HCV Guidance

HCV Guidance: Recommendations for Testing, Managing, and Treating Hepatitis C

Efficacy and safety of sofosbuvir/velpatasvir in a real-world chronic hepatitis C genotype 3 cohort

Wong YJ, Thurairajah PH, Kumar R, et al. Efficacy and safety of sofosbuvir/velpatasvir in a real-world chronic hepatitis C genotype 3 cohort. J Gastroenterol Hepatol. 2021;36(5):1300-1308.

Publication Type:

Journal Article

Authors:

Wong, YJ; Thurairajah, PH; Kumar, R; et, al

Source:

J Gastroenterol Hepatol, Volume 36, Issue 5, p.1300-1308 (2021)

Cited On:

Patients With Decompensated Cirrhosis

Export Citation:

RIS Format

Top